Tenax Therapeutics Inc (TENX)

[skyticket1]

In my opinion the volume is not big enough to be considered a sell-off.
It might be more likely that shorts try to take advantage of the technical sell indicator as it hit a new 52 weeks low. Some long term holders might give in as the company has a delay with patient enrollment which was forecasted to be finish much earlier than the end of 2016, the new low might also be the trigger that new longs are getting out again. For me it is worth the gamble and sit it out as the company has still 40 million dollars in cash, which will last until end of 2017. Read out of UK septic shock data is expected for first half 2016, which might be a good trigger for a positive stock movement as this indication (septic shock) is not in any way taken in the valuation of the company as of now. The phase 3 trial is enrolling ok-ish and could be finished in Q4 2016, so 2016 is a boom or blast year for this company - either the stock will be zero or much much higher than today. I think it is worth sitting it out especially when your cost price is much higher than todays market price. the probability that results will be good is very high as the product is already approved in over 50 countries world wide.. stay calm and believe